Browsing Terveystieteiden tiedekunta by Subject "anticancer compounds"
Now showing items 1-1 of 1
-
HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents
(Elsevier B.V., 2024)A series of hybrid inhibitors, combining pharmacophores of known kinase inhibitors bearing anilino-purines (ruxolitinib, ibrutinib) and benzohydroxamate HDAC inhibitors (nexturastat A), were generated in the present study. ...